The “miracle weight-loss drug” Ozempic, once hailed as a shortcut to shedding pounds without the hard work, is now at the center of an alarming health scare.
Dozens of Australians taking semaglutide-based medications—Ozempic, Wegovy, and Mounjaro—have come forward with reports of dr*g-induced hepatitis, a form of liver inflammation caused by medications or toxins.
Some patients were rushed to the hospital after presenting with symptoms such as vomiting, fatigue, abdominal cramps, and flu-like malaise—signs now associated with hepatotoxicity, and triggered specifically by the injectable compound.
